Evercore ISI raises Constellation Brands stock price target on guidance

Constellation Brands reported Q4 fiscal 2026 EPS of $1.90 vs $1.68 consensus (+13.1%) and revenue of $1.92B vs $1.84B, and Evercore ISI lifted its price target to $175 from $170 while maintaining an Outperform. Shares traded down premarket despite the beats as management noted cautious guidance and that tariff relief will be largely offset by higher SG&A and Veracruz expansion costs. Operational positives include a beer operating margin outlook of 37%–38% (ahead of expectations), March Circana growth of +6.5%, California market share gains, and strong FY27 hedges (fuel ~100%, aluminum ~90%, natural gas ~80%, corn ~75%, FX ~80%); Veracruz brewery expected to start mid-fiscal year.

Analysis

Constellation’s recent print shifts the debate from ‘can they grow topline’ to ‘how durable is incremental margin versus reinvestment’. Tariff relief and commodity hedges materially reduce short-term cost volatility, which should compress realized earnings downside; however, management’s willingness to absorb cost savings into SG&A and capacity buildout implies free cash flow will lag headline EBIT expansion for at least the next 1–2 fiscal years. Market-share gains in key states signal effective pricing/promotion cadence and distribution execution — that’s a structural lever that can compound margins if competitors retrench on trade spend, but it also tightens the link between marketing cadence and near-term volume sustainability.

The hedging profile is a double-edged sword: high forward coverage lowers earnings variance but increases opportunity cost if input prices decline meaningfully, creating a path-dependent upside cap to margin re-rating until hedges roll off (timing matters). On catalysts, think in three buckets — rolling commodity/FX tailwinds as hedges unwind (6–24 months), visibility on incremental brewery ramp and associated SG&A cadence (mid-term), and monthly retail data that will validate whether share shifts are sticky (near-term). Tail risks include a consumer soft patch that pressures premium mix, a reversal in tariff relief or regulatory scrutiny on cross-border capacity expansion, and a faster-than-expected decline in input costs that leaves the company over-hedged relative to peers.

Key Decisions for Investors

• Core long equity (STZ) — accumulate on any >3–6% pullbacks into a 12–18 month horizon. Target a 25–35% upside if margin guidance holds and share gains persist; hard stop at -12% if promotional elasticity shows lasting volume erosion. Rationale: asymmetric payoff from durable share gains and margin re-rate vs limited near-term FCF drag realization.
• Call-spread LEAP (STZ) — buy 12–18 month call 5–10% ITM and sell a further OTM call ~30–40% above entry to fund premium. Max loss = net premium; target 2.5–4x return if market re-rates margins and mix, protects against small downside and reduces capital outlay versus outright long.
• Pair trade — long STZ / short BUD (6–12 months) sized 1:1 by dollar exposure. Trade captures relative upside from faster domestic share recovery and stronger margin leverage at Constellation versus risk of global brewer facing higher exposure to macro softness and fx; unwind if relative weekly spread moves >15% from entry.
• Income-entry via put selling — sell 6–9 month cash-secured puts at ~10–12% OTM to collect premium, targeting effective entry below current levels. Risk: assignment and owning the equity through potential short-term volatility; use only if comfortable adding on drawdowns and set buy-to-cover if assigned and price gaps >15%.